12:00 AM
 | 
Nov 01, 1999
 |  BC Week In Review  |  Company News  |  Deals

Rigel Inc., Novartis Pharma AG deal

Rigel will use its functional genomics technology over five years to identify and validate small molecule, orally active drug targets that mediate functions of...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >